Characterization of chondrocyte scaffold carriers for cell‐based gene therapy in articular cartilage repair. Issue 12 (29th April 2013)
- Record Type:
- Journal Article
- Title:
- Characterization of chondrocyte scaffold carriers for cell‐based gene therapy in articular cartilage repair. Issue 12 (29th April 2013)
- Main Title:
- Characterization of chondrocyte scaffold carriers for cell‐based gene therapy in articular cartilage repair
- Authors:
- Shui, Wei
Yin, Liangjun
Luo, Jeffrey
Li, Ruidong
Zhang, Wenwen
Zhang, Jiye
Huang, Wei
Hu, Ning
Liang, Xi
Deng, Zhong‐Liang
Hu, Zhenming
Shi, Lewis L.
Luu, Hue H.
Haydon, Rex C.
He, Tong‐Chuan
Ho, Sherwin H. - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Articular cartilage lesions in the knee are common injuries. Chondrocyte transplant represents a promising therapeutic modality for articular cartilage injuries. Here, we characterize the viability and transgene expression of articular chondrocytes cultured in three‐dimensional scaffolds provided by four types of carriers. Articular chondrocytes are isolated from rabbit knees and cultured in four types of scaffolds: type I collagen sponge, fibrin glue, hyaluronan, and open‐cell polylactic acid (OPLA). The cultured cells are transduced with adenovirus expressing green fluorescence protein (AdGFP) and luciferase (AdGL3‐Luc). The viability and gene expression in the chondrocytes are determined with fluorescence microscopy and luciferase assay. Cartilage matrix production is assessed by Alcian blue staining. Rabbit articular chondrocytes are effectively infected by AdGFP and exhibited sustained GFP expression. All tested scaffolds support the survival and gene expression of the infected chondrocytes. However, the highest transgene expression is observed in the OPLA carrier. At 4 weeks, Alcian blue‐positive matrix materials are readily detected in OPLA cultures. Thus, our results indicate that, while all tested carriers can support the survival of chondrocytes, OPLA supports the highest transgene expression and is the most conductive scaffold for matrix production, suggesting that OPLA may be<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Articular cartilage lesions in the knee are common injuries. Chondrocyte transplant represents a promising therapeutic modality for articular cartilage injuries. Here, we characterize the viability and transgene expression of articular chondrocytes cultured in three‐dimensional scaffolds provided by four types of carriers. Articular chondrocytes are isolated from rabbit knees and cultured in four types of scaffolds: type I collagen sponge, fibrin glue, hyaluronan, and open‐cell polylactic acid (OPLA). The cultured cells are transduced with adenovirus expressing green fluorescence protein (AdGFP) and luciferase (AdGL3‐Luc). The viability and gene expression in the chondrocytes are determined with fluorescence microscopy and luciferase assay. Cartilage matrix production is assessed by Alcian blue staining. Rabbit articular chondrocytes are effectively infected by AdGFP and exhibited sustained GFP expression. All tested scaffolds support the survival and gene expression of the infected chondrocytes. However, the highest transgene expression is observed in the OPLA carrier. At 4 weeks, Alcian blue‐positive matrix materials are readily detected in OPLA cultures. Thus, our results indicate that, while all tested carriers can support the survival of chondrocytes, OPLA supports the highest transgene expression and is the most conductive scaffold for matrix production, suggesting that OPLA may be a suitable scaffold for cell‐based gene therapy of articular cartilage repairs. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 101A: 3542–3550, 2013.</p> </abstract> … (more)
- Is Part Of:
- Journal of biomedical materials research. Volume 101:Issue 12(2013)
- Journal:
- Journal of biomedical materials research
- Issue:
- Volume 101:Issue 12(2013)
- Issue Display:
- Volume 101, Issue 12 (2013)
- Year:
- 2013
- Volume:
- 101
- Issue:
- 12
- Issue Sort Value:
- 2013-0101-0012-0000
- Page Start:
- 3542
- Page End:
- 3550
- Publication Date:
- 2013-04-29
- Subjects:
- Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1552-4965 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jbm.a.34661 ↗
- Languages:
- English
- ISSNs:
- 1549-3296
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4953.720000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4165.xml